PEN

Penumbra Stock Analysis

AI Rating

Neutral
  • Quality8/10
  • Growth 8/10
  • Value 1/10
Penumbra sales and earnings growth
PEN Growth
Good
  • Revenue Y/Y 17.50%
  • EPS Y/Y 1169.44%
  • FCF Y/Y 18.76%
Penumbra gross and profit margin trends
PEN Profitability
Good
  • Gross margin 67.10%
  • EPS margin 12.70%
  • ROIC 5Y 6.45%
Penumbra net debt vs free cash flow
PEN Risk
Great
  • Debt / Equity 0.2
  • Debt / FCF 0.2
  • Interest coverage 999.0

Penumbra stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Devices stocks ↗